Differential clinical outcomes in ACS: the amplified risk of diabetes in patients treated with drug-coated balloon angioplasty
{{output}}
Background: Emerging evidence supports drug-coated balloons (DCBs) as a compelling alternative to stent-based interventions in acute coronary syndrome (ACS), particularly in diabetic populations where lesion complexity and metabo... ...
